Presentation on Thursday, October 21, 2021 during 2nd Annual DryAMD Therapeutic Development Summit

Ralf Hornig, Director of Clinical Affairs, presented at the 2nd Annual Dry AMD Therapeutic Development Summit the long-term visual results of the Prima chip in patients with geographic atrophy.

2nd-Annual-Dry-AMD-Therapeutic-Development-Virtual-Event

2021-10-22T09:59:42+02:00October 21st, 2021|Conferences, News|

Pixium Vision announces positive long-term follow-up scientific data on PRIMA implant from Prima System French feasibility study

Pixium Vision announces positive long-term data from patients implanted with PRIMA, a state-of-the-art implantable chip. The data were presented at The Eye and The Chip – Virtual Event, held October 3-5, 2021.

  • PRIMA implant is well tolerated and safe in patients 36 months after implantation
  • Implant is highly stable with no lifetime deteriorations observed
  • PRIMA can potentially provide meaningful visual acuity improvement
2021-10-13T02:53:51+02:00October 13th, 2021|News, Press Releases|

Pixium Vision to attend the 8th Annual Healthtech Investment Forum on October 5 & 6, 2021

Pixium Vision announces today that the management team will participate in the 8th Annual Healthtech Investment Forum taking place on 5th and 6th of October, 2021, digitally. More information about the event can be found here.

To request one-on-one meeting with Pixium Vision please contact Guillaume van Renterghem at gvanrenterghem@lifesciadvisors.com.

2021-10-04T19:06:55+02:00October 4th, 2021|News, Press Releases|
Go to Top